2022 Early Hearing Detection & Intervention Virtual Conference
March 13 - 15, 2022
10/24/2016 | 12:45 PM - 1:45 PM | Promoting Awareness of Congenital Cytomegalovirus to Prevent Hearing Loss | BGPOP Building 402/403/404
Promoting Awareness of Congenital Cytomegalovirus to Prevent Hearing Loss
Congenital Cytomegalovirus, or CMV, affects one in 750 babies and is the leading non-genetic cause of hearing loss. CMV causes a broad range of unilateral and bilateral hearing loss that is often progressive. However, fewer than 10% of adults in the United States are aware of CMV and the CDC-recommended precautions to take during pregnancy to prevent CMV. infections.
Awareness of congenital CMV among adults in the U.S. was assessed via the HealthStyles survey in 2005, 2010, and 2015. Despite information on the CDC website about CMV, and the American College of Obstetrics and Gynecology recommending counseling on CMV, the awareness rate of CMV in the United States is decreasing.
This presentation will provide an overview of CMV, its characteristics, methods of transmission, and methods to reduce risk of transmission during pregnancy. Presenters share data from the 2005, 2010, and 2015 HealthStyles surveys, including an analysis of what factors affect the likelihood that someone has heard of CMV.
Presenters also discuss the benefits and implications of raising CMV awareness and educating women about CMV so they can prevent disabilities by exercising precautions to prevent transmitting CMV to their unborn baby. Presenters share examples of protocol for adding CMV testing to newborn hearing screening protocol and discuss implications for diagnosis, treatment, and intervention.
- Describe the impact of CMV on hearing loss.
- Explore the potential costs and benefits of screening for CMV.
- Discuss mechanisms for promoting CMV awareness.
Presentation:
This presentation has not yet been uploaded.
Handouts:
Handout is not Available
Transcripts:
CART transcripts are NOT YET available, but will be posted shortly after the conference
Presenters/Authors
Karl White
(), NCHAM, karl.white@usu.edu;
Professor of Psychology at Utah State University and director of NCHAM
ASHA DISCLOSURE:
Financial -
Nonfinancial -
Sara Doutre
(), National Center for Hearing Assessment and Management, saradoutre@gmail.com;
Sara Doutre is a PHD student studying sociobehavioral epidemiology at Utah State University. She has an MA in education policy studies and a BS in elementary and special education. A former special education teacher and education policy professional, he currently consults with state departments of education and health on special education policy. Her four-year-old daughter is deaf due to congenital cytomegalovirus.
ASHA DISCLOSURE:
Financial -
Nonfinancial -